Jan 9, 2026 08:05AM
Nov 19, 2025 06:40AM
Nov 14, 2025 06:45AM
Nov 6, 2025 08:11AM
Oct 21, 2025 07:04AM
Oct 8, 2025 07:04AM
Aug 7, 2025 08:07AM Cartesian Therapeutics (RNAC) Tops Q2 EPS by 50c
Jul 9, 2025 06:36AM
Jun 2, 2025 06:55AM
May 30, 2025 12:12PM
May 30, 2025 07:01AM
May 8, 2025 04:29PM
Apr 8, 2025 07:01AM
Mar 17, 2025 06:45AM Cantor Fitzgerald Reiterates Overweight Rating on Cartesian Therapeutics (RNAC)
Mar 17, 2025 06:39AM
Jan 28, 2025 06:39AM
Dec 19, 2024 05:55AM
Dec 13, 2024 04:20PM
Dec 13, 2024 04:18PM
Dec 4, 2024 06:48AM
Dec 3, 2024 06:01AM Cartesian Therapeutics (RNAC) Reports Positive Updated Results from Phase 2b Trial of Descartes-08
Oct 15, 2024 07:03AM
Sep 25, 2024 02:34PM
Sep 20, 2024 04:20PM
Sep 13, 2024 06:44AM
Sep 9, 2024 04:15PM
Sep 9, 2024 07:03AM
Sep 4, 2024 07:30AM H.C. Wainwright Reiterates Buy Rating on Cartesian Therapeutics (RNAC)
Sep 3, 2024 07:05AM
Aug 9, 2024 07:33AM
Aug 8, 2024 07:23AM
Aug 6, 2024 05:31AM
Jul 3, 2024 06:40AM
Jul 3, 2024 06:33AM
Jul 2, 2024 04:07PM Cartesian Therapeutics (RNAC) Appoints Kemal Malik to its Board
Jul 2, 2024 11:27AM
Jul 2, 2024 06:32AM
Jul 2, 2024 06:32AM
Jul 2, 2024 06:30AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All